Similarly in the US, consumer price inflation in December had fallen for the first time since May 2020. Buoyed by these encouraging data points, indices on Friday ended in the green, which helped them clock marginal gains for the week.

Marksans Pharma, incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 2423.92 Crore) operating in Pharmaceuticals sector.

Despite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022

Despite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022

Through the acquisition, the company plans to double its existing Indian capacity from 8 billion units per annum currently

Shyam Century Ferrous (Re 0.3 per share) and Sun TV Network (Rs 5 per share) had announced their interim dividends. Shares of 7NR Retail will turn ex-rights today. The company had announced a rights issue of 1 share for every 1 share held, offered at Rs 1.4 apiece. Fine Organic Industries and Salem Erode Investments will have their annual general meetings (AGM) today.

Tata Consultancy Services, MMTC, Kohinoor Foods, Shrenik, Brahmaputra Infrastructure, Morarka Finance and Spectrum Foods are among companies that will announce their quarterly earnings today.

Marksans Pharmas filing to the exchanges about the buyback proposal said a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 8th July 2022 to consider the proposal for buyback of fully paid-up equity shares of the company.

An undervalued debt free small cap pharma with strong fundamentals available at a PE below 8. A potential Cup with Handle pattern is forming. Expecting price to reach green support zone highlighted, Golden FIB and Pitchfork edge is adding more confluence to that level. Good to accumulate around 35-40 levels for the following targets: Short term swing target @ 67 (78.5% ROI with 3.93 R:R) Medium term positional target @ 105 (180% ROI with 9 R:R) Long term positional target @ 180 (380% ROI …

For the year ended December 2021, Access Healthcare had revenues of Rs 25 crore and a profit after tax of Rs 9.4 crore. The company has no debt on its books.

According to reports, Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility in Goa.

Adani Group stocks tumbled up to 25 per cent before recovering. BHEL tanked 12 per cent, but Godawari Power and e-Clerx Services continued the winning streak.

Shares of Marksans Pharma rallied 20 per cent, its upper circuit limit, to Rs 83.70 on Friday. However the counter was trading at Rs 81.75 at 10.35 am. BSE Sensex was up by 297.24 points or 0.57 per cent at 52,597.71 at the same time. The stock settled at Rs 69.75 on Thursday.

While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.

In a regulatory filing on October 14, Marksans Pharma said Kacholia bought 50,99,945 shares during the quarter.

The BSE Sensex was trading 290.12 points down at 38324.67.